메뉴 건너뛰기




Volumn 10, Issue , 2011, Pages

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALEGLITAZAR; APOLIPOPROTEIN A1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN A2; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; OXAZOLE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIOPHENE DERIVATIVE;

EID: 78651560212     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-7     Document Type: Article
Times cited : (39)

References (36)
  • 1
    • 58149255300 scopus 로고    scopus 로고
    • Fact Sheet No. 312 - Diabetes
    • Fact Sheet No. 312 - Diabetes. , http://www.who.int/mediacentre/factsheets/fs312/en/
  • 2
    • 40249120466 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2008
    • American Diabetes Association
    • American Diabetes Association Standards of medical care in diabetes-2008. Diabetes Care 2008, 31(Suppl 1):S12-S54. American Diabetes Association.
    • (2008) Diabetes Care , vol.31 , Issue.SUPPL 1
  • 4
    • 0024523898 scopus 로고
    • Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys
    • Bodkin NL, Metzger BL, Hansen BC. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 1989, 256:E676-E681.
    • (1989) Am J Physiol , vol.256
    • Bodkin, N.L.1    Metzger, B.L.2    Hansen, B.C.3
  • 6
    • 0022868041 scopus 로고
    • Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey
    • 10.1007/BF00870281, 3542671
    • Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986, 29:713-719. 10.1007/BF00870281, 3542671.
    • (1986) Diabetologia , vol.29 , pp. 713-719
    • Hansen, B.C.1    Bodkin, N.L.2
  • 7
    • 0025182175 scopus 로고
    • Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys
    • Hansen BC, Bodkin NL. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 1990, 259:R612-R617.
    • (1990) Am J Physiol , vol.259
    • Hansen, B.C.1    Bodkin, N.L.2
  • 8
    • 26844515620 scopus 로고
    • Decreased hepatic insulin extraction precedes overt noninsulin dependent (type II) diabetes in obese monkeys
    • Hansen BC, Striffler JS, Bodkin NL. Decreased hepatic insulin extraction precedes overt noninsulin dependent (type II) diabetes in obese monkeys. Obes Res 1993, 1:252-260.
    • (1993) Obes Res , vol.1 , pp. 252-260
    • Hansen, B.C.1    Striffler, J.S.2    Bodkin, N.L.3
  • 9
    • 34248402754 scopus 로고    scopus 로고
    • Primate models of type 2 diabetes
    • Philadelphia: Lippincott, Williams & Wilkins, LeRoith D, Olefsky JM, Taylor SI, 3
    • Hansen BC. Primate models of type 2 diabetes. Diabetes Mellitus: A Fundamental and Clinical Text 2004, 1059-1074. Philadelphia: Lippincott, Williams & Wilkins, LeRoith D, Olefsky JM, Taylor SI, 3.
    • (2004) Diabetes Mellitus: A Fundamental and Clinical Text , pp. 1059-1074
    • Hansen, B.C.1
  • 10
    • 47249135708 scopus 로고    scopus 로고
    • The rhesus monkey (Macaca mulatta) manifests all features of human type 2 diabetes
    • New York: CRC Press, Shafrir E, 2
    • Tigno XT, Hansen BC. The rhesus monkey (Macaca mulatta) manifests all features of human type 2 diabetes. Animal Models of Diabetes: Frontiers in Research 2007, 251-270. New York: CRC Press, Shafrir E, 2., http://www.crcpress.com/product/isbn/9780849395345
    • (2007) Animal Models of Diabetes: Frontiers in Research , pp. 251-270
    • Tigno, X.T.1    Hansen, B.C.2
  • 12
    • 34248381376 scopus 로고    scopus 로고
    • Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus
    • 10.1016/j.metabol.2007.01.015, 17512318
    • Ding SY, Tigno XT, Hansen BC. Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism 2007, 56:838-846. 10.1016/j.metabol.2007.01.015, 17512318.
    • (2007) Metabolism , vol.56 , pp. 838-846
    • Ding, S.Y.1    Tigno, X.T.2    Hansen, B.C.3
  • 13
    • 0037338615 scopus 로고    scopus 로고
    • Mortality and Morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction
    • Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. Mortality and Morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction. J Gerontol A Biol Sci 2003, 58(3):212-219.
    • (2003) J Gerontol A Biol Sci , vol.58 , Issue.3 , pp. 212-219
    • Bodkin, N.L.1    Alexander, T.M.2    Ortmeyer, H.K.3    Johnson, E.4    Hansen, B.C.5
  • 14
    • 34548780737 scopus 로고    scopus 로고
    • A novel peroxisome proliferator-activated receptor α/γ dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys
    • 10.1016/j.metabol.2007.05.019, 17884441
    • Ding SY, Tigno XT, Braileanu GT, Ito K, Hansen BC. A novel peroxisome proliferator-activated receptor α/γ dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys. Metabolism 2007, 56:1334-1339. 10.1016/j.metabol.2007.05.019, 17884441.
    • (2007) Metabolism , vol.56 , pp. 1334-1339
    • Ding, S.Y.1    Tigno, X.T.2    Braileanu, G.T.3    Ito, K.4    Hansen, B.C.5
  • 15
    • 0028144529 scopus 로고
    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys
    • 10.2337/diabetes.43.2.204, 8288044
    • Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes 1994, 43:204-211. 10.2337/diabetes.43.2.204, 8288044.
    • (1994) Diabetes , vol.43 , pp. 204-211
    • Kemnitz, J.W.1    Elson, D.F.2    Roecker, E.B.3    Baum, S.T.4    Bergman, R.N.5    Meglasson, M.D.6
  • 20
    • 2942573031 scopus 로고    scopus 로고
    • Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)α activator, in non-human primates
    • Schäfer SA, Hansen BC, Völkl A, Fahimi HD, Pill J. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)α activator, in non-human primates. Biochem Pharmacol 2004, 68:239-251.
    • (2004) Biochem Pharmacol , vol.68 , pp. 239-251
    • Schäfer, S.A.1    Hansen, B.C.2    Völkl, A.3    Fahimi, H.D.4    Pill, J.5
  • 21
    • 0344586732 scopus 로고    scopus 로고
    • The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys
    • 10.1055/s-2003-43510, 14605998
    • Bodkin NL, Pill J, Meyer K, Hansen BC. The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys. Horm Metab Res 2003, 35:617-624. 10.1055/s-2003-43510, 14605998.
    • (2003) Horm Metab Res , vol.35 , pp. 617-624
    • Bodkin, N.L.1    Pill, J.2    Meyer, K.3    Hansen, B.C.4
  • 23
    • 33748672081 scopus 로고    scopus 로고
    • Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis
    • 10.1517/14728214.11.3.379, 16939380
    • Pourcet B, Fruchart JC, Staels B, Glineur C. Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis. Expert Opin Emerg Drugs 2006, 11:379-401. 10.1517/14728214.11.3.379, 16939380.
    • (2006) Expert Opin Emerg Drugs , vol.11 , pp. 379-401
    • Pourcet, B.1    Fruchart, J.C.2    Staels, B.3    Glineur, C.4
  • 24
    • 28144451163 scopus 로고    scopus 로고
    • Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    • 10.1001/jama.294.20.joc50147, 16239637
    • Nissen SE, Wolski K, Topol EJ. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA 2005, 294:2581-2586. 10.1001/jama.294.20.joc50147, 16239637.
    • (2005) JAMA , vol.294 , pp. 2581-2586
    • Nissen, S.E.1    Wolski, K.2    Topol, E.J.3
  • 25
    • 34548182594 scopus 로고    scopus 로고
    • PPAR dual agonists: are they opening Pandora's Box?
    • 10.1016/j.phrs.2007.03.002, 17428674
    • Balakumar P, Rose M, Ganti SS, Krishan P, Singh M. PPAR dual agonists: are they opening Pandora's Box?. Pharmacol Res 2007, 56:91-98. 10.1016/j.phrs.2007.03.002, 17428674.
    • (2007) Pharmacol Res , vol.56 , pp. 91-98
    • Balakumar, P.1    Rose, M.2    Ganti, S.S.3    Krishan, P.4    Singh, M.5
  • 27
    • 0003633755 scopus 로고    scopus 로고
    • Washington, DC National Academy Press, Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council
    • Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council Guide for the Care and Use of Laboratory Animals 1996, Washington, DC National Academy Press, Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council.
    • (1996) Guide for the Care and Use of Laboratory Animals
  • 28
    • 0036210564 scopus 로고    scopus 로고
    • Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy
    • Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 2002, 48:171-180.
    • (2002) Clin Lab , vol.48 , pp. 171-180
    • Otvos, J.D.1
  • 29
    • 0026644250 scopus 로고
    • Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
    • Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992, 38:1632-1638.
    • (1992) Clin Chem , vol.38 , pp. 1632-1638
    • Otvos, J.D.1    Jeyarajah, E.J.2    Bennett, D.W.3    Krauss, R.M.4
  • 30
    • 0348110533 scopus 로고    scopus 로고
    • Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus
    • 10.1016/j.amjmed.2003.08.011, 14678862
    • Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 2003, 115(Suppl 8A):24S-28S. 10.1016/j.amjmed.2003.08.011, 14678862.
    • (2003) Am J Med , vol.115 , Issue.SUPPL 8A
    • Brunzell, J.D.1    Ayyobi, A.F.2
  • 31
    • 0037317156 scopus 로고    scopus 로고
    • Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
    • 10.2337/diabetes.52.2.453, 12540621
    • Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003, 52:453-462. 10.2337/diabetes.52.2.453, 12540621.
    • (2003) Diabetes , vol.52 , pp. 453-462
    • Garvey, W.T.1    Kwon, S.2    Zheng, D.3    Shaughnessy, S.4    Wallace, P.5    Hutto, A.6    Pugh, K.7    Jenkins, A.J.8    Klein, R.L.9    Liao, Y.10
  • 32
    • 67649839953 scopus 로고    scopus 로고
    • Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
    • 10.1016/S0140-6736(09)60870-9, 19515415
    • Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M. Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. Lancet 2009, 374:126-135. 10.1016/S0140-6736(09)60870-9, 19515415.
    • (2009) Lancet , vol.374 , pp. 126-135
    • Henry, R.R.1    Lincoff, A.M.2    Mudaliar, S.3    Rabbia, M.4    Chognot, C.5    Herz, M.6
  • 33
    • 78650262266 scopus 로고    scopus 로고
    • Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: PPARγ agonist improves defective activation of atypical protein kinase C
    • 10.1089/ars.2010.3234, 20518698
    • Ortmeyer HK, Sajan MP, Miura A, Kanoh Y, Rivas J, Li Y, Standaert ML, Ryan A, Bodkin NL, Farese RV, Hansen BC. Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: PPARγ agonist improves defective activation of atypical protein kinase C. Antioxid Redox Signal 2011, 14(2):207-19. 10.1089/ars.2010.3234, 20518698.
    • (2011) Antioxid Redox Signal , vol.14 , Issue.2 , pp. 207-219
    • Ortmeyer, H.K.1    Sajan, M.P.2    Miura, A.3    Kanoh, Y.4    Rivas, J.5    Li, Y.6    Standaert, M.L.7    Ryan, A.8    Bodkin, N.L.9    Farese, R.V.10    Hansen, B.C.11
  • 34
    • 22144492005 scopus 로고    scopus 로고
    • Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys
    • 10.1194/jlr.M500002-JLR200, 15716581
    • Wallace JM, Schwarz M, Coward P, Houze J, Sawyer JK, Kelley KL, Chai A, Rudel LL. Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys. J Lipid Res 2005, 46:1009-1016. 10.1194/jlr.M500002-JLR200, 15716581.
    • (2005) J Lipid Res , vol.46 , pp. 1009-1016
    • Wallace, J.M.1    Schwarz, M.2    Coward, P.3    Houze, J.4    Sawyer, J.K.5    Kelley, K.L.6    Chai, A.7    Rudel, L.L.8
  • 35
    • 0346219295 scopus 로고    scopus 로고
    • Effect of thiazolidinediones on body weight in patients with diabetes mellitus
    • 10.1016/j.amjmed.2003.09.005, 14678865
    • Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 2003, 115(Suppl 8A):42S-48S. 10.1016/j.amjmed.2003.09.005, 14678865.
    • (2003) Am J Med , vol.115 , Issue.SUPPL 8A
    • Fonseca, V.1
  • 36
    • 68849088748 scopus 로고    scopus 로고
    • A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
    • Fisman EZ, Tenenbaum A. A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease. Cardiovas Diabetol 2009, 8:38.
    • (2009) Cardiovas Diabetol , vol.8 , pp. 38
    • Fisman, E.Z.1    Tenenbaum, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.